Clinical trials
Obesity & Overweight clinical trials
Below are recruiting obesity & overweight clinical trials, each written for real people, not researchers. We’re tracking 494 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07228130Recruiting
A weight loss study using a smartphone app
This study tests a smartphone app to help with weight loss by tracking habits. It may be a good fit if you are ready to try a new approach to managing your weight.
Providence, Rhode IslandAges 18–70 - NCT06512818Enrolling by invitationPhase 1/Phase 2
Testing Psiguavin for weight loss in obesity
This study tests a natural supplement made from guava (called Psiguavin) to see if it helps with weight loss in people who are overweight or have obesity. Participants will take the supplement and be monitored for weight changes and safety.
MurciaAges 18–65 - NCT07255274Recruiting
Sleep help for teens with overweight or obesity
This study tests whether a behavior-based sleep program can help teenagers aged 13–17 who are overweight or have obesity and also have sleep problems. The goal is to see if improving sleep can help with weight management.
CovilhaAges 13–17 - NCT04184479Recruiting
Test of a LEVAmethod program for adults with overweight
This study tests whether the LEVAmethod program helps adults with overweight or obesity when delivered in primary care. You may be asked to use digital tools and complete follow-up during the program.
GothenburgAges 18–75 - NCT07351045RecruitingPhase 3
Study of enicepatide for weight loss in obesity or overweight
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
Anniston, AlabamaAges 18 years+ - NCT07351058RecruitingPhase 3
Enicepatide for weight loss in people with type 2 diabetes
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
Guntersville, AlabamaAges 18 years+ - NCT07822230Recruiting
Dietary guidance for reducing menopause symptoms in overweight women
This trial tests whether a diet based on Brazilian dietary guidelines can help reduce menopause symptoms (like hot flashes and mood changes) in overweight or obese women. If you're in this stage and looking for non-medical ways to feel better, this study might be a good fit.
Porto Alegre, Rio Grande do SulAges 40–65 - NCT07752979RecruitingPhase 2
New drug for weight loss in adults with obesity or overweight
This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.
Pelham, AlabamaAges 18–75 - NCT07743463RecruitingPhase 3
Daily pill for weight loss in adults with excess weight or weight-related health issues
This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.
Birmingham, AlabamaAges 18 years+ - NCT07330297Recruiting
Breath test for metabolic syndrome and obesity health
This study uses a breath test to see if it can tell the difference between people with metabolic syndrome, those with obesity but otherwise healthy, and healthy controls. It aims to find a simple way to check metabolic health without blood draws.
MoscowAges 18 years+ - NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT07843472RecruitingPhase 3
Petrelintide for weight loss in people with heart disease
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
Anniston, AlabamaAges 40 years+ - NCT07670416RecruitingPhase 3
A study of enicepatide for people with obesity or overweight
This trial tests if enicepatide can help people with obesity or overweight lose weight, including those with or without type 2 diabetes. It aims to see if the drug is safe and effective.
Zhengzhou, HenanAges 18 years+ - NCT07666425Recruiting
Understanding obesity types and treatment response
This study is following people with obesity to better understand different types of obesity and what affects treatment success. By joining, you help researchers learn which treatments work best for which people.
Bologna, BolognaAges 18 years+ - NCT07402031Recruiting
Predicting weight loss from obesity treatments
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
Brussels, Brussels CapitalAges 18–65 - NCT06273072RecruitingPhase 2
Metformin for asthma in overweight adults
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
Baltimore, MarylandAges 18 years+ - NCT07159971Recruiting
Family nutrition program to prevent childhood obesity
This trial tests a family-based nutrition program to help prevent overweight and obesity in children ages 5 to 9. It is designed for families who have a smartphone and want to support healthy habits at home.
México, SonoraAges 5–9 - NCT06937086RecruitingPhase 3
Mirikizumab plus tirzepatide for UC with obesity
This study tests whether adding mirikizumab to the weight-loss drug tirzepatide helps people with moderate-to-severe ulcerative colitis who also have obesity or overweight. It aims to see if the combination reduces bowel inflammation and helps with weight management.
Dothan, AlabamaAges 18–70 - NCT07775404RecruitingPhase 3
Weight loss medication for Asian adults with obesity or overweight
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
BaotouAges 18 years+ - NCT07654374RecruitingPhase 3
Study of a new pill for weight loss and diabetes
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
Birmingham, AlabamaAges 18–79 - NCT07481747RecruitingPhase 3
Weekly injection for weight loss in adults with obesity
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
Shenzhen, GuangdongAges 18 years+ - NCT07638345Recruiting
AI-powered weight management for teens with diabetes or asthma
This study tests a smartphone app that uses artificial intelligence to help families manage weight and health for teenagers (ages 12–21) with Type 1 Diabetes or asthma. The app is designed to be personalized to each family's needs and may help improve overall health outcomes.
SevilleAges 18 years+ - NCT07794579RecruitingPhase 3
Study of orforglipron for people with overweight at risk of health problems
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
Anniston, AlabamaAges 18 years+ - NCT07654361RecruitingPhase 3
A new pill for weight loss in obesity and overweight
This study tests an investigational pill called aleniglipron to see if it helps people with obesity or overweight who also have a weight-related health problem (like high blood pressure) lose weight safely. It is a Phase 3 trial, meaning it is in the final stages before seeking approval.
Birmingham, AlabamaAges 18–79
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity & overweight?
- Yes. Clin2 currently lists 494 recruiting obesity & overweight studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity & overweight trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity & overweight trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.